Table 3.
local recurrence | distant metastases | 2 year survival | ||||
RR | 95%CI | RR | 95%CI | RR | 95%CI | |
TNM I/II | 1.0 | 1.0 | 1.0 | |||
TNM III/IV | 4.8 | 2.7-8.8 | 2.8 | 2.2-3.7 | 5.8 | 4.1-8.3 |
none/few inflammatory cells | 1.0 | 1.0 | 1.0 | |||
extensive inflammatory infiltrate | 1.7 | 0.7-4.3 | 2.6 | 1.5-4.6 | 2.4 | 1.2-4.5 |
Median follow up is 19.6 months, n = 1416. RR: relative risk, Cl: confidence interval